Quantcast
Home > Quotes > GSK

GlaxoSmithKline PLC Common Stock (GSK) Quote & Summary Data

GSK 
$40.89
*  
0.08
0.2%
Get GSK Alerts
*Delayed - data as of Jun. 22, 2018  -  Find a broker to begin trading GSK now
Exchange:NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

1 Year Target
40.65
Today's High / Low
$ 41.11 / $ 40.79
Share Volume
1,597,117
90 Day Avg. Daily Volume
2,753,188
Previous Close
$ 40.81
52 Week High / Low
$ 44.445 / $ 34.52
Market Cap
101,397,421,238
P/E Ratio
71.74
Forward P/E (1y)
14.45
Earnings Per Share (EPS)
$ 0.57
Annualized Dividend
$ 2.10
Ex Dividend Date
5/10/2018
Dividend Payment Date
7/12/2018
Current Yield
5.11 %
Beta
0.45

Special Dividend Data

Special Dividend
$ 0.1579
Special Dividend Date
Feb. 15, 2012
Special Dividend Payment Date
Apr. 12, 2012

Intraday Chart

Shares Traded

Share Volume:
1,597,117
90 Day Avg. Daily Volume:
2,753,188

P/E Ratio

P/E Ratio:
71.74
Forward P/E (1y):
14.45
Earnings Per Share (EPS):
$ 0.57

Trading Range

The current last sale of $40.89 is 18.45% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 41.11 $ 44.445
 Low: $ 40.79 $ 34.52

ETFs with GSK as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
2.05% Franklin LibertyQ International Equity Hedged ETF (FLQH) -0.90 (-3.47%)
0.02% ETF Series Solutions (ALFA) +1.58 (3.41%)
0.02% ETF Series Solutions (ALFI) -1.68 (-6.26%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

About GSK GlaxoSmithKline plc was incorporated as an English public limited company on 6 December 1999. We were formed by a merger between Glaxo Wellcome plc and SmithKline Beecham plc. GSK acquired these two English companies on 27 December 2000 as part of the merger arrangements. Our shares are listed on the London Stock Exchange and the New York Stock Exchange. > Read more at www.gsk.com [[Image Removed: LOGO]] Brand names Brand names appearing in italics throughout this report are trade marks either owned by and/or licensed to GSK or associated companies, with the exception of Edurant owned by Janssen, Cialis owned by Eli Lilly and Company and Rituxan owned by Biogen MA Inc. Zofran owned by Novartis AG and Trumenba owned by Pflzer Inc.  ... More ...  

Risk Grade

Where does GSK fit in the risk graph?


Risk Grade Scale

Consensus Recommendation

Analyst Info